Login / Signup

Early and Late Efficacy on Wound Healing of Silver Nanoparticle Gel in Males after Circumcision.

Matteo BalzarroEmanuele RubilottaNicolò TrabacchinAntonio SoldanoClara CerratoFilippo MiglioriniVito ManciniAntonio Luigi PastoreAntonio CarboneLuigi CormioGiuseppe CarrieriAlessandro Antonelli
Published in: Journal of clinical medicine (2020)
We evaluate the early and late safety and efficacy of silver nanoparticle (AgNPs) in wound healing after circumcision. This multicenter prospective comparative non-randomized observational study compares wound dressing with AgNPs (group A) vs. gentamicin cream (group B). Follow-up included objective evaluation at 10 and 30 days by the Southampton Scoring System (SSS) and Stony Brook Scar Evaluation Scale (SBSES). We enrolled 392 males: 194 in group A, and 198 in group B. At 10 days follow-up, in group A, the SSS scale was grade 1 in 49.5% and grade 2 in the remaining; meanwhile, in group B, grade 1 was in 58%, grade 2 in 34.3%, and grade 4 in 7.6%. At 30 days follow-up, grade 1 healing was 97.4% and 98.4% in group A and B, respectively. At 10 days follow-up, the mean SBSES score was 3.58 and 3.69 in group A and B, respectively; while at 30 days follow-up, 4.81 and 4.76 in group A and B, respectively. Only in group B did 7.6% of males have antibiotic therapy due to pus discharge. No patients needed surgical wound revision. AgNPs led to a late but safer healing, they were non-inferior to the antibiotic cream wound dressing efficacy, and they avoided pus discharge and the need for oral antibiotics due to their polymer material.
Keyphrases
  • wound healing
  • silver nanoparticles
  • end stage renal disease
  • double blind
  • chronic kidney disease
  • newly diagnosed
  • stem cells
  • open label
  • prognostic factors
  • surgical site infection